Sign in

CIK 0001798749

  • Emerging growth company

Jade Biosciences, Inc.

Sign in to watch
Ticker
JBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831377888
Phone
+1 781-312-3013
Business address
221 CRESCENT ST., BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aerovate Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 84 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-11-24 Dake Benjamin T SEE REMARKS Option exercise 10b5-1 +4,990 $2.14 $11K 6,281
2023-11-24 Dake Benjamin T SEE REMARKS Sale 10b5-1 −4,920 $15.74 $77K 1,361
2023-11-24 Dake Benjamin T SEE REMARKS Sale 10b5-1 −70 $16.07 $1K 1,291
2023-11-24 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −371 18,331
2023-11-24 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −4,619 139,285
2023-11-22 Dake Benjamin T SEE REMARKS Option exercise 10b5-1 +2,412 $1.74 $4K 3,703
2023-11-22 Dake Benjamin T SEE REMARKS Option exercise 10b5-1 +6,970 $2.14 $15K 10,673
2023-11-22 Dake Benjamin T SEE REMARKS Sale 10b5-1 −9,382 $15.17 $142K 1,291
2023-11-22 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −905 2,717
2023-11-22 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −1,507 15,068
2023-11-22 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −648 18,702
2023-11-22 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −6,322 143,904
2023-11-22 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise 10b5-1 +4,200 $1.74 $7K 5,809
2023-11-22 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise 10b5-1 +9,600 $2.14 $21K 15,409
2023-11-22 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Sale 10b5-1 −13,800 $15.00 $207K 1,609
2023-11-22 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −2,700 16,008
2023-11-22 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −1,500 10,588
2023-11-22 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −1,500 12,394
2023-11-22 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −3,600 38,508
2023-11-22 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −4,500 46,232

Page 12 of 16 · 315 trades